Prostate cancer prevention one step closer with outcomes of landmark genetic research

2020-09-30T06:49:44+00:00 September 11th, 2020|

Monash University’s Precision Medicine research group has discovered multiple new genetic risk factors that make men susceptible to aggressive prostate cancer, in a landmark study [...]

MPCCC research partnership with Monash BDI to improve future accuracy of precision medicine

2020-06-30T09:54:04+00:00 May 26th, 2020|

A new MPCCC partnership with Monash University’s Biomedicine Discovery Institute (Monash BDI) will investigate whether innovative research technologies, including multi-omic and organoid profiling, can improve the [...]